Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Pfizer beats EPS estimates for the 12th quarter. Explore PFE's oncology success, cost-cutting impact, and why it's rated a ...

NBCC: The company has successfully sold 446 residential units at Aspire Silicon City in Noida through an e-auction, generating Rs 1,468 crore in sales. Additionally, it will receive a marketing fee of ...

We provide a methodology for selecting high-growth dividend stocks, focusing on dividend growth and sustainability rather ...

Foreign portfolio investors remained net buyers of Indian equities for the third straight day on Friday, as they mopped up equities worth Rs 8,831.1 crore, the highest since March 27, according to the ...

At Pfizer's share price at the time of this writing ($22.87), you'd need to invest roughly $132,966 to generate $10,000 in ...

U.S. lawmakers on Thursday asked Pfizer Inc for information on alleged comments by a former executive suggesting its research ...

For investors willing to look beyond the current negative sentiment, Pfizer at today's prices represents a rare buying ...

Pharmaceutical stocks, including Pfizer (NYSE: PFE) have recently come under scrutiny following President Trump’s executive order directing drugmakers to lower medicine prices to match what ...

Below is Validea's guru fundamental report for PFIZER INC (PFE). Of the 22 guru strategies we follow, PFE rates highest using our Shareholder Yield Investor model based on the published strategy ...

The second-quarter 2025 cash dividend will be the 346th consecutive quarterly dividend paid by Pfizer. NEW YORK, April 23, 2025--Pfizer Inc. (NYSE: PFE) will showcase data across its portfolio of ...

Triumph Capital Management increased its Pfizer stake by 20%, holding over 10,000 shares worth $273,000. Several other firms ...